These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 18270260)
21. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship? McCarthy DM Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924 [TBL] [Abstract][Full Text] [Related]
22. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association. Solcia E; Capella C; Fiocca R; Rindi G; Rosai J Am J Surg Pathol; 1990 Jun; 14(6):503-13. PubMed ID: 1970928 [TBL] [Abstract][Full Text] [Related]
23. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. Rindi G; Bordi C; Rappel S; La Rosa S; Stolte M; Solcia E World J Surg; 1996 Feb; 20(2):168-72. PubMed ID: 8661813 [TBL] [Abstract][Full Text] [Related]
24. Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome. Aprile MR; Azzoni C; Gibril F; Jensen RT; Bordi C Hum Pathol; 2000 Feb; 31(2):140-8. PubMed ID: 10685627 [TBL] [Abstract][Full Text] [Related]
25. Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients. Delle Fave G; Marignani M; Corleto VD; Angeletti S; D'Ambra G; Ferraro G; D'Adda T; Azzoni C; Jensen RT; Annibale B; Bordi C Dig Liver Dis; 2002 Apr; 34(4):270-8. PubMed ID: 12038811 [TBL] [Abstract][Full Text] [Related]
26. Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas. Bashir S; Gibril F; Ojeaburu JV; Asgharian B; Entsuah LK; Ferraro G; Crafa P; Bordi C; Jensen RT Aliment Pharmacol Ther; 2002 Jul; 16(7):1367-82. PubMed ID: 12144588 [TBL] [Abstract][Full Text] [Related]
27. Gallbladder and gastric argyrophil carcinoid associated with a case of Zollinger-Ellison syndrome. Barone GW; Schaefer RF; Counce JS; Eidt JF Am J Gastroenterol; 1992 Mar; 87(3):392-4. PubMed ID: 1539581 [TBL] [Abstract][Full Text] [Related]
28. Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up. Daniels LM; Khalili M; Morano WF; Simoncini M; Mapow BC; Leaf A; Bowne WB World J Surg Oncol; 2019 Dec; 17(1):213. PubMed ID: 31818296 [TBL] [Abstract][Full Text] [Related]
29. Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: a prospective study. Gibril F; Reynolds JC; Lubensky IA; Roy PK; Peghini PL; Doppman JL; Jensen RT J Nucl Med; 2000 Oct; 41(10):1646-56. PubMed ID: 11037994 [TBL] [Abstract][Full Text] [Related]
30. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Ito T; Igarashi H; Uehara H; Berna MJ; Jensen RT Medicine (Baltimore); 2013 May; 92(3):135-181. PubMed ID: 23645327 [TBL] [Abstract][Full Text] [Related]
31. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids. Peracchi M; Gebbia C; Basilisco G; Quatrini M; Tarantino C; Vescarelli C; Massironi S; Conte D Eur J Endocrinol; 2005 Mar; 152(3):443-8. PubMed ID: 15757862 [TBL] [Abstract][Full Text] [Related]
32. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole. Hage E; Hendel L; Gustafsen J; Hendel J Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309 [TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of ECL cell tumors. Cadiot G; Cattan D; Mignon M Yale J Biol Med; 1998; 71(3-4):311-23. PubMed ID: 10461362 [TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole. Hirschowitz BI; Haber MM Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282 [TBL] [Abstract][Full Text] [Related]
36. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature. Berna MJ; Hoffmann KM; Serrano J; Gibril F; Jensen RT Medicine (Baltimore); 2006 Nov; 85(6):295-330. PubMed ID: 17108778 [TBL] [Abstract][Full Text] [Related]
37. Praomys (Mastomys) natalensis: a model for gastric carcinoid formation. Nilsson O; Wängberg B; Johansson L; Modlin IM; Ahlman H Yale J Biol Med; 1992; 65(6):741-51; discussion 827-9. PubMed ID: 1341076 [TBL] [Abstract][Full Text] [Related]
38. Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids. Jianu CS; Fossmark R; Syversen U; Hauso Ø; Fykse V; Waldum HL Scand J Gastroenterol; 2011 Apr; 46(4):456-63. PubMed ID: 21133821 [TBL] [Abstract][Full Text] [Related]
39. Management of carcinoid tumors of the stomach, duodenum, and pancreas. Akerström G World J Surg; 1996 Feb; 20(2):173-82. PubMed ID: 8661814 [TBL] [Abstract][Full Text] [Related]
40. Carcinogenic hypergastrinemia: signet-ring cell carcinoma in a patient with multiple endocrine neoplasia type 1 with Zollinger-Ellison's syndrome. Schott M; Sagert C; Willenberg HS; Schinner S; Ramp U; Varro A; Raffel A; Eisenberger C; Zacharowski K; Perren A; Scherbaum WA J Clin Endocrinol Metab; 2007 Sep; 92(9):3378-82. PubMed ID: 17609302 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]